Evaluating Tumor Heterogeneity with a High Throughput Pipeline
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
An automated bioprinting and imaging platform allows researchers to examine heterogeneous responses to anticancer drugs within a tumor organoid population.
rare cancers
Infographic: Rare Disease by the Numbers
The Scientist | Apr 30, 2018 | 1 min read
How rare conditions and research spending on them compare with more common diseases.